Worth reading
48Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
-15.2
% (year-on-year change in operating income)Wording
Avoiding a definitive answer
How definitive the wording is.Results for this period
Full year1 July 2025 to 30 June 2026ConsolidatedJapanese GAAPNet Sales126,595¥ millionYear on year +3.2%
Operating profit1,679¥ millionYear on year -15.2%
Ordinary income1,664¥ millionYear on year -15.2%
Net income attributable to owners of the parent1,112¥ millionYear on year -22.2%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit.
Net income per share¥187.67
Operating Margin1.3％
Financial position at period-end
Total assets46,653¥ million
of which net assets 13,061 ¥ millionEquity ratio 28.0%vs. prior year-end +1.3pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Cash inflows and outflows
Operating+864
Investment-1,105
Financials-590
Net change-831
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Cash and cash equivalents at end of period¥2,590 million
Segment revenueMedical Equipment Business ¥117,720,937 thousand (YoY +3.1%), SPD Business ¥5,964,183 thousand (YoY +6.6%), Care Products Business ¥2,910,498 thousand (YoY +4.8%)
Segment profitMedical Equipment Business ¥1,466,434 thousand (YoY -17.3%), SPD Business ¥119,575 thousand (YoY +5.0%), Care Products Business ¥245,400 thousand (YoY +19.6%)
Outlook and shareholder returns
Full-year earnings forecast
Net SalesForecast value Undecided / Year-on-year change Undecided
Operating profitForecast value Undecided / Year-on-year change Undecided
Ordinary incomeForecast value Undecided / Year-on-year change Undecided
Net incomeForecast value Undecided / Year-on-year change Undecided
Annual Dividend Forecast¥80 → Undecided（Undecided）
Payout ratio42.6
Factors Behind Changes in Business Performance
Profit was below the previous year due to the inability to fully pass higher procurement, inventory management and delivery costs on to selling prices, salary base increases, system investments for OLBA-DX, and one-off expenses such as fees related to the management integration.
Disclosure regarding the going concern assumption
No applicable matters.
Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNew 0 / Excluded 0 / Company name None
Material subsequent eventsNo applicable matters.
Impairment lossNot applicable (¥0 thousand)
Breakdown of extraordinary income (loss)Extraordinary income Gain on sale of property, plant and equipment ¥132,931 thousand, Gain on sale of investment securities ¥99 thousand / Extraordinary loss Loss on sale of property, plant and equipment ¥19,602 thousand, Loss on disposal of property, plant and equipment ¥2,537 thousand, Loss on disposal of intangible assets ¥82 thousand
Depreciation and amortization¥743,207 thousand
Availability of Supplementary Financial Results MaterialsNo
Availability of Financial Results BriefingYes (for analysts)
Issued Shares at Period-End6,250,000
Treasury Shares at Period-End321,972
| Item | Details |
|---|---|
| Fiscal Period Classification | Full year |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 July 2025 to 30 June 2026 |
| Net Sales | ¥126,595 million (YoY +3.2%) |
| Operating profit | ¥1,679 million (YoY -15.2%) |
| Ordinary income | ¥1,664 million (YoY -15.2%) |
| Profit attributable to owners of the parent | ¥1,112 million (YoY -22.2%) |
| Net income per share | ¥187.67 |
| Operating Margin | 1.3％ |
| Equity ratio | End of the current fiscal period 28 / End of previous period 26.7 |
| Total assets | ¥46,653 million |
| Net assets | ¥13,061 million |
| Cash flows from operating activities | ¥864 million |
| Cash flows from investing activities | ¥-1,105 million |
| Cash flows from financing activities | ¥-590 million |
| Cash and cash equivalents at end of period | ¥2,590 million |
| Full-year earnings forecast | Net Sales Forecast value Undecided / Year-on-year change Undecided / Operating profit Forecast value Undecided / Year-on-year change Undecided / Ordinary income Forecast value Undecided / Year-on-year change Undecided / Net income Forecast value Undecided / Year-on-year change Undecided |
| Annual Dividend Forecast | ¥80 → Undecided（Undecided） |
| Payout ratio | 42.6 |
| Segment revenue | Medical Equipment Business ¥117,720,937 thousand (YoY +3.1%), SPD Business ¥5,964,183 thousand (YoY +6.6%), Care Products Business ¥2,910,498 thousand (YoY +4.8%) |
| Segment profit | Medical Equipment Business ¥1,466,434 thousand (YoY -17.3%), SPD Business ¥119,575 thousand (YoY +5.0%), Care Products Business ¥245,400 thousand (YoY +19.6%) |
| Depreciation and amortization | ¥743,207 thousand |
| Impairment loss | Not applicable (¥0 thousand) |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of property, plant and equipment ¥132,931 thousand, Gain on sale of investment securities ¥99 thousand / Extraordinary loss Loss on sale of property, plant and equipment ¥19,602 thousand, Loss on disposal of property, plant and equipment ¥2,537 thousand, Loss on disposal of intangible assets ¥82 thousand |
| Disclosure regarding the going concern assumption | No applicable matters. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New 0 / Excluded 0 / Company name None |
| Material subsequent events | No applicable matters. |
| Availability of Supplementary Financial Results Materials | No |
| Availability of Financial Results Briefing | Yes (for analysts) |
| Issued Shares at Period-End | 6,250,000 |
| Treasury Shares at Period-End | 321,972 |
| Factors Behind Changes in Business Performance | Profit was below the previous year due to the inability to fully pass higher procurement, inventory management and delivery costs on to selling prices, salary base increases, system investments for OLBA-DX, and one-off expenses such as fees related to the management integration. |
Items this document does not state (4)
Revision to Earnings ForecastShareholder Return PolicyRegional salesOrders received and order backlog
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The Company was unable to fully pass on to selling prices the increases in procurement costs resulting from higher prices, as well as higher inventory management and delivery costs. It also recorded expenses for salary base increases, system investments to promote OLBA-DX, and one-off costs such as fees related to the management integration.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.